Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. XRF Scientific's current 1-Year Share Buyback Ratio was -1.80%.
ASX:XRF's 1-Year Share Buyback Ratio is ranked worse than 71.71% of 258
companies
in the Conglomerates industry
Industry Median: -0.1
vs ASX:XRF: -1.80
XRF Scientific (ASX:XRF) 1-Year Share Buyback Ratio Explanation
A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
XRF Scientific 1-Year Share Buyback Ratio Related Terms
ASX:XRF vs MMM, HON: 1-Year Share Buyback Ratio Comparison
For the Conglomerates subindustry, XRF Scientific's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
XRF Scientific 1-Year Share Buyback Ratio vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, XRF Scientific's 1-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where XRF Scientific's 1-Year Share Buyback Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 1-Year Share Buyback Ratio of -1.80 mean?
XRF Scientific (ASX:XRF) has a 1-Year Share Buyback Ratio of -1.80 as of Dec. 2025. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for XRF Scientific and its competitors. According to the industry distribution chart, XRF Scientific ranks #185 out of 258 companies in the Conglomerates industry, placing it in the top 71.7%.
Is XRF Scientific's 1-Year Share Buyback Ratio too high?
XRF Scientific's current 1-Year Share Buyback Ratio is -1.80. Based on the distribution chart, XRF Scientific ranks #185 out of 258 companies in the Conglomerates industry, which is below the industry midpoint. Overall, XRF Scientific has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does XRF Scientific's 1-Year Share Buyback Ratio compare to MMM and HON?
According to the Conglomerates industry distribution chart, XRF Scientific ranks #185 out of 258 companies for 1-Year Share Buyback Ratio. This places XRF Scientific in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Share Buyback Ratio for a Conglomerates company?
A good 1-Year Share Buyback Ratio depends on the Conglomerates industry context. However, 1-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Share Buyback Ratio mean?
A high 1-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for XRF Scientific and its competitors. XRF Scientific's current 1-Year Share Buyback Ratio is -1.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XRF Scientific stock overvalued right now?
Based on GuruFocus' analysis, XRF Scientific (ASX:XRF) is currently considered Fairly Valued. The stock's GF Value™ is A$1.67, compared to a current price of A$1.81 — trading 8.1% above its estimated fair value. The current 1-Year Share Buyback Ratio is -1.80. XRF Scientific's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Share Buyback Ratio calculated?
1-Year Share Buyback Ratio is calculated from a company's financial statements. For XRF Scientific (ASX:XRF), the current 1-Year Share Buyback Ratio is -1.80 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is XRF Scientific (ASX:XRF) Overvalued in 2026?
Based on GuruFocus' analysis, XRF Scientific stock appears to be overvalued.
The current stock price of A$1.81 is trading 8.1% above its estimated GF Value™ of A$1.67.
GuruFocus considers XRF Scientific to be Fairly Valued.
Key valuation signals for ASX:XRF:
1-Year Share Buyback Ratio: -1.80
GF Value™: A$1.67 vs. price of A$1.81 (8.1% above fair value)
No single metric tells the full story. See the ASX:XRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
XRF Scientific Ltd is engaged in the business of manufacturing and marketing precious metal products, specialized chemicals and instruments for the scientific, analytical and mining industries. It operates through the following segments: Capital Equipment, Precious Metals, and Consumables. The company generates maximum revenue from the Capital Equipment segment that Manufactures sample preparation products and analytical instruments. Geographically, it derives a majority of revenue from Australia and also has a presence in Canada and Europe. Some of its product includes Electric Fusion Machines; Fusion Flux; Crushing and Pulverising, platinum lab ware and others.
92GF Score
Get the complete analysis for ASX:XRF
1-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:XRF has been successfully added to your 
